The bile acid TUDCA promotes chemoresistance and predicts survival through MAPK signaling in pancreatic ductal adenocarcinoma.

Cell Mol Life Sci · 2026 · PMC13247006 · PMID 42033493

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

However, after combining with TUDCA, a decreasing trend in the inhibitory effect of gemcitabine was observed across all four cell lines (Fig. 5 B).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.